METHOD OF TREATING PATIENTS OVER 50 YEARS OLD SUFFERING SECONDARY HYPOTHYROIDISM Russian patent published in 2011 - IPC A61K31/505 A61P5/14 A61P7/02 

FIELD: medicine.

SUBSTANCE: invention refers to treating the patients over 50 years old suffering secondary hypothyroidism progressing as a result of surgical management of chiasmatic-cellar tumours. That is ensured by administration of thyreohormones in dose increased every 2 months to a therapeutic dose and observed hypothyroidism correction. There are also evaluated thrombocyte aggregation, packed cell volume, and thrombocyte count. If observing spontaneous thrombocyte aggregation (STA) more than 1 %, adenosine diphosphate (ADP) thrombocyte aggregations more than 75 %, with normal or higher packed cell volume: than 50 % in male patients, than 42 % in female patients, with thrombocyte count either normal, or exceeding 320*10⁹/l, the disaggregant Curantyl 75 mg/day is also prescribed to ensure hypothyroidism correction.

EFFECT: decreased thrombocyte aggregation, improved microcirculation processes, immune status that in turn enables reducing side effects of hormonotherapy and time of selection of thyreohormone dosage.

2 ex